Zhang Ting, M.D., Ph.D.

Department:Radiation Oncology

Medical School:Zhejiang University School of Medicine, China

Academic Rank:Associate Chief Physician


Appointment

Clinical / Research Interests

Multidisciplinary treatment and radiotherapy of nasopharyngeal cancers, head and neck carcinoma, breast cancer, lung cancer, esophageal carcinoma, glioma, lymphomas and soft tissue sarcoma.

Professional Highlights

Professional Appointments

Committee Member, Clinical Immunology Committee, Zhejiang Immunological Society

Education Experience

Research Summary

Engaged in the fields of cancer radiotherapy, radiation-induced immune response, differentiation and regulation of immune cells.

Publications

Zhang T, Yu H, Ni C, et al. Hypofractionated stereotactic radiation therapy activates the peripheral immune response in operable stage I non-small-cell lung cancer. Sci Rep. 2017 Jul 7;7(1):4866.

Gu M, Zhang T, lin W, et al. Protein phosphatase PP1 negatively regulates the Toll-like receptor- and RIG-I-like receptor-triggered production of type I interferon by inhibiting IRF3 phosphorylation at serines 396 and 385 in macrophage. Cell Signal. 2014 Dec;26(12):2930-9. 

Zhang T, Liu S, Yang P, et al. Fibronectin maintains survival of mouse natural killer (NK) cells via CD11b/Src/beta-catenin pathway. Blood. 2009 Nov 5;114(19):4081-8.



Current Program

Protein Phosphatase 1 Negative Regulate TLR Signal Pathway and The Underling Molecular Mechanisms. Funding Source: Youth Program of National Natural Science Foundation.

B cell subset B10 promotes immune escape of human breast cancer and the related molecular mechanisms. Funding Source: Natural Science Foundation of Zhejiang.

The mechanism of epigenetic variation of tumor-related macrophage differentiation under hypoxic conditions. Funding Source: Natural Science Foundation of Zhejiang.

Find People

Search by Family Name

Find A Department

Search by Departments